MONICA BANG: Open Payments
NPI 1417378159 · MURPHY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 24 payments from 11 companies in 2025. Trend: 2023 $2,330 · 2024 $2,360 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $141 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| UCB, Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| ABBVIE INC. | 3 | $45 |
| GENZYME CORPORATION | 2 | $36 |
| PFIZER INC. | 1 | $23 |
| Organon LLC | 3 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
Products named: OTEZLA, DUPIXENT, Bimzelx, COSENTYX, SKYRIZI, CIBINQO, VTAMA, Zoryve.
Industry payments across TX — which companies pay providers there.
